Covid 19

Current awareness updates

Interim Clinical Commissioning Policy: Neutralising monoclonal antibodies and intravenous antivirals in the treatment of COVID-19 in hospitalised patients.
Department of Health and Social Care (DHSC); 2021.
[This rapid policy statement from 24th December outlines the eligibility criteria for the use of casirivimab with imdevimab or sotrovimab for patients hospitalised with COVID-19, and those with hospital onset COVID-19.]

The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations.
Goossens H. The Lancet Infectious Diseases 2021;:doi.org/10.1016/S1473-3099(21)00705-2.
[We discuss how the clinical research community responded to the pandemic in Europe, what lessons were learned, and provide recommendations for future clinical research response during pandemics. We focused on two platform trials: RECOVERY and REMAP-CAP.]

Remote general practitioner consultations during COVID-19.
Green MA. The Lancet Digital Health 2022;4(1):E7.
[[Letter.] Advances in digital technology had already stimulated debate on consultation methods; despite offering convenience for some patients, there were concerns about widening inequalities for others. Given that the pandemic offered a natural experiment to assess the potential implications of remote consultations, we analysed data from NHS Digital to better understand these implications. Our analyses showed that any suggestion that GPs were not seeing patients in person was not true.]

Delivering outpatient virtual clinics during the COVID-19 pandemic: early evaluation of clinicians’ experiences.[Abstract]
Vas V. BMJ Open Quality 2022;11(1):doi: 10.1136/bmjoq-2020-001313.
[Conclusions: In response to the pandemic, outpatient services across the trust were rapidly redesigned and virtual clinics implemented. As a result, services have been able to sustain some level of service delivery. However, clinicians have identified challenges in delivering this model of care and highlighted enablers needed to sustaining the delivery of virtual clinics longer term, such as patient access to diagnostic tests and investigations closer to home.]

CG Report 6: Effects of COVID-19 In Care Homes: A Mixed Methods Review.
Collateral Global; 2021.
[The report, using national datasets for 25 countries on mortality, provides an up-to-date review of global effects of COVID-19 pandemic in care homes, assessing care home mortality by country, how the deaths compared with previous periods, and how excess deaths may be explained.]

Regulation and use of confidential patient information for genomic and medical research during and post Covid-19.
PHG Foundation; 2021.
[At the start of the Covid-19 pandemic the government in England introduced measures to enable the use of confidential patient information for Covid-19 purposes without consent or another form of approval that would normally be required. This report considers how these regulatory changes to the governance of confidential patient information have impacted genomic and medical research, and whether these changes should be integrated into the regulatory framework longer term.]

Frequently asked questions: Demonstrating Covid-19 and vaccination status.
House of Commons Library; 2021.
[This briefing sets out responses to FAQs about demonstrating Covid status (otherwise called Covid status certification or vaccine passports) and use of the NHS Covid Pass in England.]

Clearing the backlog caused by the pandemic: ninth report of Session 2021–22.
House of Commons Health and Social Care Committee; 2021.
[This report finds that elective recovery plans are threatened by pressure on emergency care with a record number of 999 calls and waiting times in emergency departments at record levels. It concludes that tackling the wider backlog caused by the pandemic is a major and ‘unquantifiable’ challenge. It calls for a broad national health and care recovery plan to include mental health, primary care, community care and social care as well as emergency care.]

Telephone survey two: PCNs and Covid-19.
PRUComm; 2021.
[The purpose of the telephone survey was to try to understand the role primary care networks (PCNs) had played in response to the Covid-19 pandemic, focusing on whether the pandemic had influenced and shaped the development and operation of PCNs and whether PCNs had worked collectively or as individual practices in their Covid-19 response. This short report comprises data collected between August and December 2020.]

Inequality and the Covid crisis in the United Kingdom.
Institute for Fiscal Studies (IFS); 2022.
[IFS Working Paper W22/01. This report reviews the effects on the Covid-19 pandemic on inequalities in education, the labour market, household living standards, mental health and wealth in the UK.]

Effects of COVID-19 lockdown on eating disorders and obesity: A systematic review and meta-analysis.[Abstract]
Sideli L. European Eating Disorders Review 2021;29(6):826-841.
[The majority of individuals with EDs and obesity reported symptomatic worsening during the lockdown. However, further longitudinal studies are needed to identify vulnerable groups, as well as the long-term consequences of COVID-19.]

Public Health

Current awareness updates

Prostate cancer.
National Institute for Health and Care Excellence (NICE); 2021.
[This quality standard covers managing prostate cancer in people referred to secondary care or having follow-up for prostate cancer in primary care. It describes high-quality care in priority areas for improvement. In December 2021, changes were made to align this quality standard with the updated NICE guideline on prostate cancer.]

Combined adult and paediatric respiratory clinical assessment service (RCAS) hubs for acute respiratory infection.
NHS England and NHS Improvement; 2021.
[This document supports systems to plan for a likely rise in respiratory infections (for example, Covid-19, respiratory syncytial virus (RSV), influenza and other infections) this winter.]

Our Vision for the Women’s Health Strategy for England.
Department of Health and Social Care (DHSC); 2021.
[Analysis of call for evidence consultation response has informed development of this document, which is published alongside the consultation response. This document sets out the government’s vision and the publication of the strategy will follow in 2022.]

Children and young people’s mental health:eighth Report of Session 2021–22.
House of Commons Health and Social Care Committee; 2021.
[This report calls for urgent action to prevent mental health services slipping backwards as a result of additional demand created by the pandemic and the scale of unmet need prior to it. MPs found that despite progress in numbers of young people receiving treatment, it was unacceptable that more than half with a diagnosable condition pre-pandemic do not receive the mental health support they need.]

Public Health Report from Deloitte

Bridging the gap: Protecting the nation from public health threats

The third report in the future of public health series examines the UK’s policies and approach to health protection including the availability of the specialist resources, knowledge and skills needed to tackle the many diverse and challenging public health threats.

Download the report here.

Public Health

Current awareness updates

Our ageing population: How ageing affects health and care need in England.
The Health Foundation; 2021.
[This report examines this dynamic by analysing changes in two measures of need:  an estimate of social care need, drawn from the English Longitudinal Study of Ageing (ELSA) ; prevalence of long-term conditions, as a proxy for health and health service demand.   It explores how health and care needs change with age, how the relationship between need and age has changed over time and how long-term conditions and social care needs interact.]

National Diabetes Audit, Report 1- Care Processes and Treatment Targets 2020-21.
NHS Digital; 2021.
[The National Diabetes Audit measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards.]

Humidification of indoor air for preventing or reducing dryness symptoms or upper respiratory infections in educational settings and at the workplace. [Abstract]
Byber K. Cochrane Database of Systematic Reviews 2021;12:CD012219.
[OBJECTIVES: To determine the effectiveness of interventions that increase indoor air humidity in order to reduce or prevent dryness symptoms of the eyes, the skin and the upper respiratory tract (URT) or URT infections, at work and in educational settings.]

Public Health

Current awareness updates

The cost effectiveness of ecotherapy as a healthcare intervention, separating the wood from the trees.
Hinde S. International Journal of Environmental Research and Public Health (IJERPH) 2021;18(-):11599.
[This paper explores the capacity for ecotherapy to be cost-effective as a healthcare intervention. We show that there is the potential for ecotherapy for people with mild to moderate common mental health problems to be cost-effective but significant further research is required.]

Community support versus health care services: time to change our definition of impact.
Evidence & Policy Blog; 2021.
[Non-profit community anchor organisations in England typically provide a range of support to local people, including wellbeing support, advocacy, social activities, and training and employment advice. This array of services takes a wider perspective on the determinants of health than the approach taken within the NHS, which generally focuses on mental and physical ill health. Despite the different approaches, the funding for organisations is often dependent on the impact on health outcomes.]

National Pregnancy in Diabetes (NPID) Audit Report 2019.
Healthcare Quality Improvement Partnership (HQIP); 2021.
[The National Pregnancy in Diabetes (NPID) Audit measures the quality of antenatal care and pregnancy outcomes for women with pre-gestational diabetes. Overall, there were 4,525 pregnant women with diabetes in 2020 – 325 fewer pregnancies than 2019 – of which, 54% had type 2 diabetes (44% had type 1 diabetes and 2% were recorded as having ‘other diabetes’). The audit includes analysis by age, ethnicity, social deprivation and weight.]

Better together: a public health model for mentally healthier integrated care systems.
Centre for Mental Health; 2021.
[According to this briefing paper, England’s 42 integrated care systems have an opportunity to protect and promote mental health in the communities they serve. The briefing explores how integrated care systems can address the social and environmental factors that affect people’s health in their communities.]

Saving lives, improving mothers’ care: lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2017-19.
National Perinatal Epidemiology Unit (NPEU); 2021.
[This report finds that pregnancy remains safe in the UK, with the overall maternal death rate showing a slight decrease. Among 2,173,810 women who gave birth in 2017-2019, 191 died during or up to six weeks after pregnancy, and 495 during or up to one year after their pregnancy. However, the findings show a continued inequality in the mortality rates for women of different ethnic backgrounds, ages and socio-economic circumstances.]

Ethnic and socio-economic Inequalities in NHS maternity and perinatal care for women and their babies.
Healthcare Quality Improvement Partnership (HQIP); 2021.
[This report describes inequalities in maternity and perinatal care for women and their babies in England, Scotland and Wales during the period 1 April 2015 to 31 March 2018. Using routinely collected data, care and outcomes experienced by women and babies using NHS maternity services are measured and stratified by ethnicity and by Index of Multiple Deprivation (IMD), a proxy for socio-economic deprivation.]

Fulfilling the promise: how social prescribing can most effectively tackle loneliness.
British Red Cross; 2021.
[This report draws on practical experience of delivering social prescribing services to those experiencing or at risk of loneliness through Red Cross Community Connector schemes.]

What works when evaluating social prescribing? A realist review report.
Wales School for Social Prescribing Research; 2021.
[An analysis of approaches used to evaluate social prescribing.]

Newcastle GP Services Social Prescribing Navigator Service: an independent evaluation.
North of England Commissioning Support Network; 2021.
[The aims of this evaluation were to: • Understand the update and usage of the service across Newcastle with regards population, conditions, and sites. • Analyse trends in unplanned access to secondary care. • Understand the experience and impact from the patient as end user of this service and navigators as deliverers of the service • Recommend data collection and analysis for the ongoing service to have greater comprehension of the impact of the service.]

The role of data in unlocking the potential of social prescribing.
Open Data Institute; 2021.
[A report by Frontier Economics for the ODI concludes there are a number of barriers to social prescribing reaching its full potential, including the lack of available data, and solid data infrastructure, such as statistics, maps and real-time service-use data that could help social prescribers and the providers of services to make decisions, build services and gain insight.]


Covid 19

Current awareness updates

COVID-19: infection prevention and control (IPC).
UK Health Security Agency (UKHSA); 2021.
[November 2021 Updates: 1) Guidance broadened to include seasonal respiratory infections; 3 COVID-19 specific pathways removed; section on the hierarchy of controls added; physical distancing advice updated. 2) Updated to clarify text on aerosol generating procedures. 3) Dental appendix broadened to include seasonal respiratory infections; 3 COVID-19 specific pathways removed and replaced with respiratory and non-respiratory pathways.]

COVID-19 rapid guideline: managing COVID-19
National Institute for Health and Care Excellence (NICE); 2021.
[In November, NICE added a new recommendation on ivermectin.]

Daily Insight: Another test for NHS staff.
HSJ: Health Service Journal (Daily Insight) 2021;:7031436.
[A letter sent by Chris Whitty, Ruth May and Susan Hopkins has strengthened expectations on NHS staff who have just returned from abroad. NHS workers returning from any non red-list country must have a negative PCR test before returning to work. Also: New guidance has recommended that trusts relax the segregation of patients according to covid-19 risk. There is likely to be a developing picture on infection control guidance over the next few weeks in light of the Omicron variant. 30 November.]

Frequently asked questions: Demonstrating Covid-19 and vaccination status.
House of Commons Library; 2021.
[This briefing paper provides answers to frequently asked questions about demonstrating Covid-19 status (otherwise called Covid-19 status certification) and use of the NHS Covid Pass in England.]

Covid-19 status certification.
House of Commons Library; 2021.
[Covid-19 status certification (also referred to as a “vaccine passport”) has been proposed as a means of reducing the risk of transmitting the Covid-19 virus in a number of settings. This briefing explores the Government’s policy on certification. It also provides discussion on the scientific evidence and other issues associated with the use of certification.]

Responding to violence against women and children during COVID-19: impact on service provision, strategies and actions in the WHO European Region (2021).
World Health Organization (WHO); 2021.
[A new report published by WHO/Europe shows that helplines providing support to women and children experiencing violence saw a spike in calls during the first 9 months of the COVID-19 pandemic. The data in the new report was collected between January and September 2020, a time in which millions of people in the WHO European Region were confined to their homes because of lockdowns or other restrictive measures.]

UK vaccine response to the Omicron variant: JCVI advice.
Department of Health and Social Care (DHSC); 2021.
[Advice from the Joint Committee on Vaccination and Immunisation (JCVI) in response to the emergence of the Omicron variant. This statement sets out the JCVI’s advice on extending the UK COVID-19 vaccination programme to offer booster doses to adults aged 18 to 39 years, and second doses to children and young people aged 12 to 15 years.]

Adfam Research

Overlooked: why we should be doing more to support families and friends affected by someone else’s drinking, drug use or gambling

This report examines Adfam’s latest research with YouGov on the prevalence of people currently negatively affected by the drinking, drug use or gambling of a family member or friend in 2021, and the different challenges and impacts these families currently face. The report’s findings highlight the need for more recognition of the impacts on families and friends and it includes recommendations on how to better support this overlooked group.

Covid 19

Current awareness updates

COVID-19: letter to patients on end of shielding programme.
UK Health Security Agency (UKHSA); 2021.
[Reference-only version of letter from the government to patients on the end of the shielding programme.]

COVID-19 rapid guideline: managing the long-term effects of COVID-19.
National Institute for Health and Care Excellence (NICE); 2021.
[This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. On 11 November, NICE made new recommendations and updated existing recommendations on identification; planning care; multidisciplinary rehabilitation; follow up, monitoring and discharge; and service organisation. NICE also updated the list of common symptoms, emphasising that these may be different for children.]

COVID-19 booster vaccine programme for winter 2021 to 2022: JCVI statement, November 2021.
Department of Health and Social Care (DHSC); 2021.
[This statement sets out further advice from JCVI on extension of the booster programme to revaccinate adults aged 40 to 49 years against COVID-19. The main aim of this booster vaccination programme is to reduce deaths, serious disease and hospitalisations from COVID-19 over the 2021 to 2022 winter period and through 2022.]

Why we think you should say yes to the COVID-19 vaccine.
Leeds Clinical Commissioning Group; 2021.
[An information leaflet about the COVID-19 vaccine where clinicians and faith leaders highlight the importance of having the vaccine. The leaflet has been translated into the following languages: Amharic, Arabic, Bengali, Czech, Farsi, Kurdish Sorani, Polish, Punjabi, Romanian, Slovak, Tigrinya and Urdu. Audio versions of the leaflet are available for each of those languages.]

No one wants to see my baby: challenges to building back better for babies.
Parent-Infant Foundation; 2021.
[This report explores the continued impact of Covid-19 on babies. It consists of a survey of professionals, in-depth studies with 11 families and a review of the literature, conducted with partner organisations Home-Start and Best Beginnings. The report shows that many services across the UK are not operating as they were before the pandemic, and babies and their families are missing out as a result.]

Essential and Invisible: Filipino irregular migrants in the UK’s ongoing COVID-19 crisis.
Kanlungan Filipino Consortium; 2021.
[For many in the United Kingdom, it might feel as if the “crisis” of the COVID-19 pandemic is coming to an end. Yet for irregular migrants, the pandemic has become a protracted struggle to survive. This report is based on interviews with Filipino irregular migrants based in the UK conducted in Spring 2021, compared to the same interviewees’ responses in Spring 2020.]

Coronavirus: support for landlords and tenants.
House of Commons Library; 2021.
[This briefing explains measures during the coronavirus outbreak to help renting households retain their homes. It covers calls for more assistance to prevent evictions and homelessness.]

Nuffield Trust Report

Attracting, supporting and retaining a diverse NHS workforce

This report, commissioned by NHS Employers, examines the representation of under-served groups and provide a set of recommendations for change as the NHS strives to become an exemplar of equality, diversity and inclusion.

Covid 19

Current awareness updates

Face coverings and COVID-19: statement from an expert panel .
UK Health Security Agency (UKHSA); 2021.
[An expert panel statement, informed by evidence and expertise, on the role of face coverings in mitigating COVID-19 transmission.]

Impact evaluation of the Coronavirus Community Support Fund: final report.
The National Lottery Community Fund; 2021.
[Ipsos MORI, in partnership with New Philanthropy Capital (NPC) and The Tavistock Institute of Human Relations (TIHR), was commissioned to undertake an evaluation of the Coronavirus Community Support Fund (CCSF). This document summarises the findings from an assessment of the impact the CCSF had on the people and communities that were supported, the organisations that were funded, and the volunteers involved.]

COVID-19: impact on childhood vaccinations: data to August 2021.
UK Health Security Agency (UKHSA); 2021.
[Final report of the series providing an early assessment of the impact of COVID-19 on delivery of childhood vaccination programmes in England.]

Covid and beyond: confronting the unequal access to type 1 diabetes healthcare.
Juvenile Diabetes Research Foundation; 2021.
[JDRF surveyed more than 1,000 people living with type 1 diabetes, or caring for a child living with it, to reveal their experiences through the upheavals of the Covid pandemic. The findings of the report reveal the impact of the withdrawal and repurposing of many NHS diabetes services on people with type 1. The report sets out a series of recommendations, anchored in the needs of people living with type 1.]

Assessing the impact of COVID-19 on the clinically extremely vulnerable population.
The Health Foundation; 2021.
[This briefing presents analysis from the Networked Data Lab on the impact the pandemic has had on the clinically extremely vulnerable population; assesses the mental health of people identified as clinically extremely vulnerable; examines the data on access to care for clinically extremely vulnerable;
assess the limitations to the use of an algorithm-driven approach to identifying the clinically extremely vulnerable population which were exacerbated by poor availability of high-quality data.]